Bet on Volatility in VIX

Feb. 7 (Bloomberg) -- In today's "Options Insight," Trading Advantage Senior Market Strategist Scott Bauer and Bloomberg’s Scarlett Fu examine an options strategy for VIX in “On The Markets” on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)

Teva Said Close to Closing $40.5 Billion Allergan Deal
20:07 - The U.S. Federal Trade Commission is close to signing off on Teva Pharmaceutical's deal to buy Allergan Plc's generics unit for $40.5 billion according to people familiar with the matter. Bloomberg's Elliot Gotkine reports on "Bloomberg Markets Middle East." (Source: Bloomberg)
  • Bracing for Yet Another Global Banking Crisis
  • Brexit Brews Trouble for SABMiller-AB InBev Deal
  • Ford CEO: Brexit and Lower Pound Hurt Us